vs
Array Technologies, Inc.（ARRY）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Array Technologies, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$226.0M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -17.9%），Array Technologies, Inc.自由现金流更多（$36.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 21.4%）
ATI科技是原加拿大半导体科技企业，总部位于安大略省万锦市，专注于图形处理器与芯片组的研发，1985年成立，1993年公开上市，2006年被AMD收购。作为全球知名的无晶圆厂半导体厂商，其掌握自研核心技术，生产组装环节采用外包模式。2000年3dfx破产后，ATI成为全球图形芯片领域的核心厂商之一。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ARRY vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $226.0M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 8.6% | — |
| 营业利润率 | -65.5% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | -17.9% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-1.06 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $226.0M | $207.3M | ||
| Q3 25 | $393.5M | $159.9M | ||
| Q2 25 | $362.2M | $166.5M | ||
| Q1 25 | $302.4M | $139.3M | ||
| Q4 24 | $275.2M | $164.6M | ||
| Q3 24 | $231.4M | $139.5M | ||
| Q2 24 | $255.8M | $147.0M | ||
| Q1 24 | $153.4M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $33.5M | $-180.4M | ||
| Q2 25 | $43.3M | $-115.0M | ||
| Q1 25 | $16.7M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-141.4M | $-133.5M | ||
| Q2 24 | $25.7M | $-131.6M | ||
| Q1 24 | $2.2M | $-170.7M |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 26.9% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 28.5% | — | ||
| Q3 24 | 33.8% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 35.9% | — |
| Q4 25 | -65.5% | -54.7% | ||
| Q3 25 | 11.6% | -106.9% | ||
| Q2 25 | 12.8% | -64.8% | ||
| Q1 25 | 9.0% | -102.6% | ||
| Q4 24 | -51.7% | -74.3% | ||
| Q3 24 | -57.3% | -94.6% | ||
| Q2 24 | 15.5% | -79.1% | ||
| Q1 24 | 5.5% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | 8.5% | -112.8% | ||
| Q2 25 | 11.9% | -69.0% | ||
| Q1 25 | 5.5% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -61.1% | -95.7% | ||
| Q2 24 | 10.0% | -89.5% | ||
| Q1 24 | 1.4% | -156.8% |
| Q4 25 | $-1.06 | $-1.28 | ||
| Q3 25 | $0.12 | $-1.81 | ||
| Q2 25 | $0.19 | $-1.17 | ||
| Q1 25 | $0.02 | $-1.57 | ||
| Q4 24 | $-0.94 | $-1.34 | ||
| Q3 24 | $-1.02 | $-1.40 | ||
| Q2 24 | $0.08 | $-1.52 | ||
| Q1 24 | $-0.07 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $244.4M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-206.3M | $-80.0M |
| 总资产 | $1.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $244.4M | $421.0M | ||
| Q3 25 | $221.5M | $202.5M | ||
| Q2 25 | $377.3M | $176.3M | ||
| Q1 25 | $348.3M | $127.1M | ||
| Q4 24 | $363.0M | $174.0M | ||
| Q3 24 | $332.4M | $150.6M | ||
| Q2 24 | $282.3M | $480.7M | ||
| Q1 24 | $287.6M | $112.3M |
| Q4 25 | $-206.3M | $-80.0M | ||
| Q3 25 | $-46.7M | $9.2M | ||
| Q2 25 | $-70.9M | $151.3M | ||
| Q1 25 | $-97.8M | $144.2M | ||
| Q4 24 | $-118.1M | $255.0M | ||
| Q3 24 | $64.5M | $346.8M | ||
| Q2 24 | $200.0M | $432.4M | ||
| Q1 24 | $231.2M | $140.3M |
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.7B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $43.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $36.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 16.0% | -48.6% |
| 资本支出强度资本支出/营收 | 3.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $79.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $43.6M | $-99.8M | ||
| Q3 25 | $27.4M | $-91.4M | ||
| Q2 25 | $43.8M | $-108.3M | ||
| Q1 25 | $-13.1M | $-166.5M | ||
| Q4 24 | $57.6M | $-79.3M | ||
| Q3 24 | $44.9M | $-67.0M | ||
| Q2 24 | $4.0M | $-77.0M | ||
| Q1 24 | $47.5M | $-190.7M |
| Q4 25 | $36.2M | $-100.8M | ||
| Q3 25 | $21.9M | $-92.7M | ||
| Q2 25 | $37.2M | $-110.7M | ||
| Q1 25 | $-15.4M | $-167.8M | ||
| Q4 24 | $55.9M | $-79.5M | ||
| Q3 24 | $43.9M | $-68.6M | ||
| Q2 24 | $1.8M | $-79.0M | ||
| Q1 24 | $45.1M | $-193.9M |
| Q4 25 | 16.0% | -48.6% | ||
| Q3 25 | 5.6% | -58.0% | ||
| Q2 25 | 10.3% | -66.5% | ||
| Q1 25 | -5.1% | -120.5% | ||
| Q4 24 | 20.3% | -48.3% | ||
| Q3 24 | 19.0% | -49.2% | ||
| Q2 24 | 0.7% | -53.7% | ||
| Q1 24 | 29.4% | -178.2% |
| Q4 25 | 3.3% | 0.5% | ||
| Q3 25 | 1.4% | 0.8% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 0.8% | 1.0% | ||
| Q4 24 | 0.6% | 0.1% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.8% | 1.4% | ||
| Q1 24 | 1.6% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | -0.78× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 21.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARRY
| Array Legacy Operations Segment | $212.0M | 94% |
| STI Operations Segment | $14.0M | 6% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
